Koers Delta 9 Cannabis Inc Toronto S.E.
Aandelen
CA2477541049
Farmaceutische producten
Omzet 2024 * | 75,8 mln. 55,35 mln. 51,47 mln. | Omzet 2025 * | 86,6 mln. 63,24 mln. 58,81 mln. | Marktkapitalisatie | 8,68 mln. 6,34 mln. 5,89 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | 0,11 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 0,1 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 83,89% |
Recentste transcriptie over Delta 9 Cannabis Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Arbuthnot
CEO | Chief Executive Officer | 34 | 01-01-12 |
James Lawson
DFI | Director of Finance/CFO | 73 | - |
Todd Schubert
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hugh Aird
BRD | Director/Board Member | 70 | 07-09-18 |
Nitin Kaushal
CHM | Chairman | 58 | 31-10-17 |
John Arbuthnot
CEO | Chief Executive Officer | 34 | 01-01-12 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,08% | 662 mld. | |
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
-3,40% | 157 mld. |